Related Experiment Video
Updated: May 14, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
The potential role of HMGB1 release in peritoneal dialysis-related peritonitis
Shirong Cao1, Shu Li, Huiyang Li
1Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Key Laboratory of Nephrology, Ministry of Health, Guangzhou, China.
Abstract:
High mobility group box 1 (HMGB1), a DNA-binding nuclear protein, has been implicated as an endogenous danger signal in the pathogenesis of infection diseases. However, the potential role and source of HMGB1 in the peritoneal dialysis (PD) effluence of patients with peritonitis are unknown. First, to evaluate HMDB1 levels in peritoneal dialysis effluence (PDE), a total of 61 PD patients were enrolled in this study, including 42 patients with peritonitis and 19 without peritonitis. Demographic characteristics, symptoms, physical examination findings and laboratory parameters were recorded. HMGB1 levels in PDE were determined by Western blot and ELISA. The concentrations of TNF-α and IL-6 in PDE were quantified by ELISA. By animal model, inhibition of HMGB1 with glycyrrhizin was performed to determine the effects of HMGB1 in LPS-induced mice peritonitis. In vitro, a human peritoneal mesothelial cell line (HMrSV5) was stimulated with lipopolysaccharide (LPS), HMGB1 extracellular content in the culture media and intracellular distribution in various cellular fractions were analyzed by Western blot or immunofluorescence. The results showed that the levels of HMGB1 in PDE were higher in patients with peritonitis than those in controls, and gradually declined during the period of effective antibiotic treatments. Furthermore, the levels of HMGB1 in PDE were positively correlated with white blood cells (WBCs) count, TNF-α and IL-6 levels. However, pretreatment with glycyrrhizin attenuated LPS-induced acute peritoneal inflammation and dysfunction in mice. In cultured HMrSV5 cells, LPS actively induced HMGB1 nuclear-cytoplasmic translocation and release in a time and dose-dependent fashion. Moreover, cytosolic HMGB1 was located in lysosomes and secreted via a lysosome-mediated secretory pathway following LPS stimulation. Our study demonstrates that elevated HMGB1 levels in PDE during PD-related peritonitis, at least partially, from peritoneal mesothelial cells, which may be involved in the process of PD-related peritonitis and play a critical role in acute peritoneal dysfunction.
Insights
Elevated High mobility group box 1 (HMGB1) in peritoneal dialysis effluence indicates peritonitis. HMGB1, released from peritoneal mesothelial cells, contributes to inflammation and dysfunction during infection.
Area of Science:
- Nephrology
- Immunology
- Cell Biology
Background:
- High mobility group box 1 (HMGB1) is an inflammatory mediator.
- The role and source of HMGB1 in peritoneal dialysis (PD) effluence during peritonitis are unclear.
Purpose of the Study:
- To investigate HMGB1 levels in PD effluence (PDE) of patients with peritonitis.
- To explore the cellular source and mechanism of HMGB1 release in PD-related peritonitis.
Main Methods:
- Measured HMGB1, TNF-α, and IL-6 levels in PDE from 61 PD patients (42 with peritonitis, 19 controls) using Western blot and ELISA.
- Utilized an animal model to assess HMGB1 inhibition effects with glycyrrhizin on LPS-induced peritonitis.
- Investigated HMGB1 release from lipopolysaccharide (LPS)-stimulated human peritoneal mesothelial cells (HMrSV5) in vitro.
Main Results:
- HMGB1 levels were significantly higher in PD patients with peritonitis compared to controls.
- PDE HMGB1 levels correlated positively with white blood cells (WBCs), TNF-α, and IL-6.
- Glycyrrhizin treatment attenuated LPS-induced peritonitis in mice; LPS stimulated HMGB1 release from HMrSV5 cells via a lysosome-mediated pathway.
Conclusions:
- Elevated HMGB1 in PDE during peritonitis originates partly from peritoneal mesothelial cells.
- HMGB1 may play a critical role in the pathogenesis and dysfunction associated with PD-related peritonitis.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Gastritis II: Pathophysiology
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Peritoneum
Anatomy of the Peritoneum
The peritoneum is divided into two layers: the parietal peritoneum and the visceral...
Acute Pancreatitis II: Pathophysiology

